Yes, leukemia is a type of blood cancer, but the two terms aren’t interchangeable. Blood cancer is the broader category, and leukemia is one of three major types within it. The other two are lymphoma and multiple myeloma. All three originate in the blood-forming organs, but they develop in different cells, show up in different parts of the body, and behave in distinct ways.
How Leukemia Fits Under Blood Cancer
Think of “blood cancer” as an umbrella. Underneath it sit leukemia, lymphoma, and multiple myeloma. Each one involves the uncontrolled growth of a specific type of blood cell, but where that growth starts and how it spreads sets them apart.
Leukemia begins in the bone marrow, the spongy tissue inside your bones where blood cells are made. It happens when white blood cells pick up genetic mutations that tell them to keep dividing instead of maturing normally. These abnormal cells eventually crowd out the healthy ones, which means your body produces fewer of the cells it needs to fight infections, carry oxygen, and form clots. Unlike many other cancers, leukemia doesn’t form solid tumors. It’s a liquid cancer that circulates through your bloodstream.
How Leukemia Differs From Lymphoma and Myeloma
Lymphoma also involves white blood cells, but it starts in the lymphatic system rather than the bone marrow. The cancerous cells, called lymphocytes, multiply too fast and collect in lymph nodes, forming solid masses. One of the earliest signs of lymphoma is swollen lymph nodes in the armpit, groin, or abdomen. Leukemia, by contrast, stays in the blood and marrow without producing tumors.
Multiple myeloma targets a different cell entirely: plasma cells, which are mature white blood cells responsible for producing antibodies. In myeloma, these plasma cells grow out of control in the bone marrow. Though myeloma shares that bone marrow origin with leukemia, the specific cell type involved and the way the disease progresses are quite different. In rare cases, myeloma can evolve into a leukemia-like state where malignant plasma cells spill into the bloodstream, a condition called plasma cell leukemia.
The Four Main Types of Leukemia
Leukemia itself breaks down further based on two factors: how fast it progresses and which type of white blood cell it affects. The speed distinction separates acute from chronic forms. The cell type distinction separates lymphocytic (affecting lymphocytes) from myeloid (affecting a different group of white blood cells called granulocytes).
That gives you four main types:
- Acute lymphocytic leukemia (ALL) grows rapidly and involves immature lymphocytes. It’s the most common childhood leukemia.
- Acute myeloid leukemia (AML) also grows rapidly but involves immature myeloid cells. It’s more common in adults.
- Chronic lymphocytic leukemia (CLL) progresses slowly and involves partially mature lymphocytes, particularly B cells. It mainly affects older adults.
- Chronic myeloid leukemia (CML) progresses slowly and involves partially mature granulocytes.
In acute forms, the cancerous cells are so immature they can’t perform any useful function at all. They multiply fast, and symptoms appear quickly. In chronic forms, the cells are partially developed. They still don’t work properly, but they accumulate more slowly, sometimes over years, in the blood and lymphoid organs.
What Leukemia Feels Like
Because leukemia disrupts the production of all healthy blood cells, its symptoms reflect those shortages. Too few red blood cells causes fatigue, weakness, and pale skin. Too few platelets leads to easy bruising, frequent nosebleeds, and bleeding gums. Too few functioning white blood cells means infections come more often and take longer to resolve.
Other common signs include unexplained weight loss, night sweats, fever, and bone or joint pain. Many of these symptoms overlap with non-cancerous conditions like iron-deficiency anemia or viral infections, which is part of why leukemia can be tricky to recognize early. The key difference is that in leukemia, multiple symptoms tend to appear together and persist or worsen over weeks rather than resolving on their own. Acute forms can progress noticeably within days.
How Leukemia Is Diagnosed
A standard blood test is usually the first step. A complete blood count reveals whether white blood cell numbers are abnormally high or low, and a blood smear lets doctors look at the cells under a microscope. In acute leukemia, the hallmark finding is circulating blast cells, immature cells that shouldn’t be present in the bloodstream. The percentage of blasts can range from just a few percent to nearly 100%.
If blood tests raise suspicion, the next step is a bone marrow biopsy. A small sample of marrow is drawn from the hip bone and examined. Under the current classification system, a blast percentage above 20% in the bone marrow confirms a diagnosis of acute leukemia. Additional lab techniques then identify the exact subtype by looking at surface markers on the cells and checking for specific chromosomal abnormalities. These details matter because different subtypes respond to different treatments.
Survival and Outlook
The overall five-year survival rate for leukemia is about 68.6%, based on recent data from the National Cancer Institute’s SEER program. That number is an average across all subtypes, ages, and stages, so individual outlooks vary widely. Chronic forms like CLL often progress so slowly that many people live with the disease for decades. Acute forms require immediate, intensive treatment but can also be curable, especially ALL in children, where cure rates now exceed 90% with modern therapy.
Survival rates have improved substantially over the past few decades thanks to targeted treatments that attack the specific genetic changes driving each subtype. CML, for example, was once considered almost uniformly fatal within a few years. Today, most people with CML have a near-normal life expectancy with ongoing treatment.